MCETMultiCell Technologies, Inc.

About MultiCell Technologies, Inc. (MCET)

MultiCell Technologies, Inc. (MCET) is a Biotechnology company headquartered in Dallas, TX, United States whose shares trade over-the-counter on the Expert Market tier.

MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease, fatigue of MS and cancer. The majority owned Xenogenics subsidiary is developing a drug-eluting cardiac stent.

MCET key facts

Ticker symbol

MCET

Market tier

Expert Market

Sector

Healthcare

Industry

Biotechnology

Headquarters

Dallas, TX, United States

Country of incorporation

US

Year of incorporation

1970

Employees

3

Estimated market cap

$1.00M (as of Oct 7, 2024)

Shares outstanding

5,000,988,700

Reporting standard

Dark: Alternative Reporting Standard

Audit status

Not Available

Fiscal year end

11/30

MultiCell Technologies, Inc. leadership

• Edward Sigmond — President

Explore more: Biotechnology stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with M